Page last updated: 2024-08-25

cromakalim and Angor Pectoris

cromakalim has been researched along with Angor Pectoris in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, WA; Coghlan, MJ; Gopalakrishnan, M1
Falotico, R; Giardino, EC; Katz, LB; Moore, JB; Salata, JJ1
Carr, CS; Yellon, DM1
Aisaka, K; Hirata, Y; Mabuchi, Y; Miyai, H1
Dixon, MS; Sheridan, DJ; Thomas, P; Winterton, SJ1

Reviews

1 review(s) available for cromakalim and Angor Pectoris

ArticleYear
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
    Journal of medicinal chemistry, 2001, May-24, Volume: 44, Issue:11

    Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence

2001

Trials

1 trial(s) available for cromakalim and Angor Pectoris

ArticleYear
Acute haemodynamic effects of cromakalim in patients with angina pectoris.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:3

    Topics: Adult; Aged; Angina Pectoris; Benzopyrans; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Cromakalim; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pyrroles; Stroke Volume; Vascular Resistance; Vasodilator Agents

1990

Other Studies

3 other study(ies) available for cromakalim and Angor Pectoris

ArticleYear
RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

    Topics: Angina Pectoris; Animals; Antihypertensive Agents; Benzopyrans; Bronchoconstriction; Calcium Channel Blockers; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; Ferrets; Gastrointestinal Motility; Guinea Pigs; Heart Atria; Macaca mulatta; Male; Mice; Mice, Inbred Strains; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrendipine; Papillary Muscles; Pilocarpine; Potassium Channels; Pyrans; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rubidium; Rubidium Radioisotopes; Thiophenes; Vasodilator Agents

1993
Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
    Basic research in cardiology, 1997, Volume: 92, Issue:4

    Topics: Adenosine Triphosphate; Adult; Aged; Angina Pectoris; Benzopyrans; Cromakalim; Female; Guanidines; Heart Atria; Humans; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Contraction; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents

1997
Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:2

    Topics: Administration, Oral; Angina Pectoris; Animals; Arginine Vasopressin; Blood Pressure; Chromans; Cromakalim; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Injections, Intravenous; Male; Methacholine Chloride; Molecular Structure; Niacinamide; Nicorandil; Nifedipine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents

1998